期刊文献+

白念珠菌生物被膜基质研究进展 被引量:4

Advances in the matrix of Candida albicans biofilms
下载PDF
导出
摘要 近年来,白念珠菌耐药性备受关注,其耐药机制之一是形成生物被膜(biofilm)。生物被膜主要由大量菌细胞及其所分泌的细胞外多聚基质(matrix)将其包裹所构成,基质含有多糖、蛋白、核酸等成分,不仅参与生物被膜的结构组成,也与耐药性密切相关。本文综述了白念珠菌生物被膜基质的组成特点、功能、影响因素、基因调控和药物干预的最新进展,并展望其在生物被膜感染方面作为诊断标志及治疗靶点的潜在应用前景。 Recently, more and more attention was being paid to resistance of Candida albicans to antifungal drugs. One of the resistance mechanisms was attributed to biofilm formation. The biofilms strongly attached to biologic or nonbiologic substrata were mainly made up of communities of microorganisms enclosed within a self-produced extracellular matrix. Consisting of polysaccharides, proteins, nucleic acids, etc. the matrix is not only involved in biofilm structure formation but also closely related to the resistance to therapeutic agents. This review focused on recent information about chemical compositions and properties, functions, influencing factors, gene regulation, and drug treatment of biofilm matrix, and discussed its potential applications as diagnostic marker and therapeutic target.
出处 《中国真菌学杂志》 2012年第3期178-183,共6页 Chinese Journal of Mycology
基金 国家自然科学基金(81073127) 安徽省自然科学基金(090413092) 安徽省高校省级自然科学研究重点项目(KJ2010A220)
关键词 白念珠菌 生物被膜 基质 耐药性 Candida albicans biofilms matrix resistance
  • 相关文献

参考文献1

  • 1Al-Fattani MA, Douglas LJ. Biofilm matrix of Candida albicans and Candida tropicalis:chemical composition and role in drug resistance[J]. J Med Microbiol,2006,55(Pt 8):999-1008.

同被引文献39

  • 1李冰昱,万启南.鱼腥草注射液治疗老年人肺炎的临床观察[J].国际中医中药杂志,2006,28(3):151-154. 被引量:12
  • 2巢国祥,焦新安,周丽萍,周晓辉,朱炳炎.食源性金黄色葡萄球菌流行特征、产肠毒素特性及耐药性研究[J].中国卫生检验杂志,2006,16(8):904-907. 被引量:67
  • 3张娜,韩北忠,李敏,张琳.食品接触表面对金黄色葡萄球菌生物被膜形成的影响[J].食品研究与开发,2006,27(7):33-35. 被引量:17
  • 4Ying Y, Zhao Y, Hu X, et al. In Vitro fluconazole susceptibility of 1,903 clinical isolates of candida albicans and the identification of ERG11 mutations [ J/OL ]. Microb Drug Resist, 2013, [ 2013 - 03 - 13 ]. http ://www. ncbi. nlm. nih. gov/pubmed/?.
  • 5Dunkel N, Liu TT, Barker KS, et al. A gain-of-function mutation in the transcription factor Upc2p causes upregulation of ergosterolbio- synthesis genes and increased fluconazole resistance in a clinical Candida albicans isolate[J]. Eukaryot Cell, 2008, 7(7) : 1180 - 1190.
  • 6Chandra J, Kuhn DM, Mukherjee PK, et al. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance[J]. J Bacteriol, 2001, 183(18): 5385 - 5394.
  • 7White TC. Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus [J]. Antimicrob Agents Chemother, 1997, 41 (7): 1482-1487.
  • 8Sanglard D, Kuchler K, lscher F, et al. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific muhidrug transporters [ J ]. Antimicrob Agents Chemother, 1995, 39 ( 11 ) : 2378 - 2386.
  • 9Niimi M, Niimi K, Takano Y, et al. Regulated overexpression of CDRI in Candida albicans confers multidrug resistance[J]. J Antlmicrob Chemother, 2004, 54 (6) : 999 - 1006.
  • 10Coste A, Turner V, Ischer F, et al. A mutation in Taclp, a tran- scription factor regulating CDR1 and CDR2. is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candidaalbicans[J]. Genetics, 2006, 172(4): 2139 -2156.

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部